Flosonics Medical Secures $20 Million Usd In Series C Funding Led By New Leaf Venture Partners To Accelerate Growth

By Author: otis
Total Articles: 388
Comment this article

Flosonics Medical, a pioneer in wearable medical ultrasound technology, has successfully raised $20 million USD in Series C funding. New Leaf Venture Partners led the investment round, with participation from existing investors Arboretum Ventures, Genesys Capital, and iGan Partners. This financial backing will further support Flosonics' continuous innovation and market adoption of FloPatch, a revolutionary wearable Doppler ultrasound device for hemodynamic assessments.

This funding round signifies a major achievement for Flosonics, validating its past successes and empowering the company to expedite its growth and innovation initiatives. With a primary focus on improving the quality of care for critically ill patients, Flosonics intends to utilize the funding to drive business expansion, broaden the scope of applications, and advance its evidence-generating efforts.

Vijay Lathi, a seasoned MedTech investor, will be joining Flosonics Medical’s board of directors, expressing great enthusiasm for the collaboration and the potential positive impact of Flosonics' technology on patient outcomes.

Established in 2015, Flosonics Medical is dedicated to enhancing patient care and medical practices through technology-driven solutions and cutting-edge clinical research. The company's specialization in wearable ultrasound technology positions it as a frontrunner in healthcare innovation.

Read More - https://www.techdogs.com/tech-news/business-wire/flosonics-medical-secures-20-million-usd-in-series-c-funding-led-by-new-leaf-venture-partners-to-accelerate-growth